Tissue inhibitor of metalloproteinase-3 differentially binds to components of Bruch's membrane

British Journal of Ophthalmology

Volumn 90, Issue 10, 2006, Pages 1310-1315

  Majid, M A ^b   Smith, V A ^a,b   Matthews, F J ^b   Newby, A C ^b   Dick, A D ^b  

^a BRISTOL EYE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN 4 SULFATE; CHONDROITIN 6 SULFATE; CHONDROITIN SULFATE; COLLAGEN TYPE 1; COLLAGEN TYPE 4; DERMATAN SULFATE; ELASTIN; FIBRONECTIN; HEPARAN SULFATE; LAMININ; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ANIMAL CELL; ARTICLE; BRUCH MEMBRANE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE DISEASE; EYE FUNDUS; MEMBRANE BINDING; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SYNTHESIS; SORBY FUNDUS DYSTROPHY;

ANIMALS; BRUCH MEMBRANE; CERCOPITHECUS AETHIOPS; CORNEAL DYSTROPHIES, HEREDITARY; COS CELLS; ELASTIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; LAMININ; POINT MUTATION; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TRANSFECTION;

EID: 33750311612     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2006.097246     Document Type: Article

References (30)

1. Sorsby A, Mason MEJ. A fundus dystrophy with unusual features. Br J Ophthalmol 1949;33:67-97.
2. Weber BHF, Vogt G, Wok W, et al. Sorsby's fundus dystrophy is genetically linked to chromosome 22q13-qter. Nat Genet 1994;7:158-61.
3. Weber BHF, Vogt G, Pruett RC, et al. Mutations in the tissue inhibitor of metalloproteinase-3 (TIMP-3) in patients with Sorsby's fundus dystrophy. Nat Genet 1994;8:352-6.
4. Hamilton WK, Ewing CC, Ives EJ, et al. Sorsby's fundus dystrophy. Ophthalmology 1989;96:1755-62.
5. Polkinghorne PJ, Capon MRC, Berninger T, et al. Sorsby's fundus dystrophy. A clinical study. Ophthalmology 1989;96:1763-8.
6. Capon MR, Polkinghorne PJ, Fitzke FW, et al. Sorsby's pseudo-inflammatory macula dystrophy - Sorsby's Fundus dystrophies. Eye 1988;2:114-22.
7. Capon MRC, Marshall J, Krafft JI, et al. Sorsby's fondus dystrophy. A light and electron microscopic study. Ophthalmology 1989;96:1769-77.
8. Chong NHV, Alexander RA, Gin T, et al. TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy. Invest Ophthalmol Vis Sci 2000;41:898-902.
9. Kamei M, Apte SS, Rayborn ME, et al. TIMP-3 accumulation in Bruch's membrane and drusen in eyes from normal and age-related macular degeneration donors. In: La Vail MM, Anderson RE, Hollyfield JG, eds. Degenerative diseases of the retina. New York: Plenum Press, 1997.
10. Loechel F, Fox JW, Murphy G, et al. ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. Biochem Biophys Res Commun 2000;278:511-15.
11. Amour A, Slocombe PM, Webster A, et al. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett 1998;435:39-44.
12. Kashiwagi M, Tortorella M, Nagase H, et al. TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5). J Biol Chem 2001;276:12501-4.
13. Willenbrock F, Murphy G. Structure function relationships in the tissue inhibitors of metalloproteinases. Am J Respir Crit Care Med 1994;150:S165-70.
14. Yu WH, Yu S, Meng Q, et al. TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix. J Biol Chem 2000;275:31226-32.
15. Majid MA, Smith VA, Easly DL, et al. Over-expression of wild type and Sorsby's mutant tissue inhibitor of metalloproteinases-3 differentially induce apoptosis in retinal pigment epithelial cells. FEBS Lett 2002;529:281-5.
16. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
17. Della NG, Campochiaro PA, Zack DJ. Localization of TIMP-3 mRNA expression to the retinal pigment epithelium. Invest Ophthalmol Vis Sci 1996;37:1921-4.
18. Fariss RN, Apte SS, Olsen BR, et al. Tissue inhibitor of metalloproteinase-3 is a component of Bruch's membrane of the eye. Am J Pathol 1997;16:102-10.
19. Fariss RN, Apte SS, Luthert PJ, et al. Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa. Br J Ophthalmol 1998;82:1329-34.
20. Jomary C, Neal MJ, Iwata K, et al. Localisation of tissue inhibitor of metalloproteinases-3 in neurodegenerative retinal disease. Neuroreport 1997;8:2169-72.
21. Kamei M, Hollyfield, JG. TIMP-3 in Bruch's membrane: changes during ageing and in age-related macular degeneration. Invest Ophthalmol Vis Sci 1999;40:2367-75.
22. Ruiz A, Brett P, Bok O. TIMP-3 is expressed in the human pigment epithelium. Biochem Biophys Res Commun 1996;226:467-74.
23. Vranka JA, Johnson E, Zhu X, et al. Discrete expression and distribution pattern of TIMP-3 in the human retina and choroid. Curr Eye Res 1997;16:102-10.
24. Bian JH, Wang YL, Smith MR, et al. Suppression of in vivo tumor-growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP-3). Carcinogenesis 1996;17:1805-11.
25. Baker AH, Zaltsman AB, George SJ, et al. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 over-expression on rat vascular smooth muscle cell invasion, proliferation and death in vitro. J Clin Invest 1998;101:1478-87.
26. Ahonen M, Baker A, Veli-Matti K. Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinase-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res 1998;58:2310-15.
27. Smith MR, Kung H, Durum SK, et al. TIMP-3 induces cell death by stabilising TNF-α receptors on the surface of human colon carcinoma cells. Cytokine 1997;9:770-80.
28. Majid MA, Smith VA, Easty DL, et al. Adenovirus mediated gene delivery of tissue inhibitor of metalloproteinases-3 induces death in retinal pigment epithelial cells. Br J Ophthalmol 2002;86:97-101.
29. Langton KP, Barker MD, McKie N. Localization of the functional domains of human tissue inhibitor of metalloproteinases-3 and the effects of a Sorsby's fundus dystrophy mutation. J Biol Chem 1998;273:16778-81.
30. Bond M, Murphy G, Bennett MR, et al. Localization of the death domain of tissue inhibitor of metalloproteinase-3 to the N terminus. Metalloproteinase inhibition is associated with proapoptotic activity. J Biol Chem 2000;275:41358-63.